ACN
54
2
APA
57
-2
HUM
31
-4
OXY
41
9
MCK
60
-2
EOG
50
-4
ZION
64
3
EXPE
81
-2
SWK
56
-2
VIX
49
3
IR
65
2
COP
45
-2
TAP
29
-8
BRK.B
36
-4
EMN
53
3
APD
27
-7
FIS
63
-4
ILMN
70
2
DTE
36
-2
CPB
32
-8
ACN
54
2
APA
57
-2
HUM
31
-4
OXY
41
9
MCK
60
-2
EOG
50
-4
ZION
64
3
EXPE
81
-2
SWK
56
-2
VIX
49
3
IR
65
2
COP
45
-2
TAP
29
-8
BRK.B
36
-4
EMN
53
3
APD
27
-7
FIS
63
-4
ILMN
70
2
DTE
36
-2
CPB
32
-8
Financhill
Back

Keysight Technologies, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Buy
77

KEYS
Keysight Technologies, Inc.

Last Price:
$212.81
Seasonality Move:
3.68%
Buy
87

KYMR
Kymera Therapeutics, Inc.

Last Price:
$89.98
Seasonality Move:
7.7%
Buy
77
Keysight Technologies, Inc. (KEYS) is a Buy

Is Keysight Technologies, Inc. a Buy, Sell or Hold?

  • The current Keysight Technologies, Inc. [KEYS] share price is $210.46. The Score for KEYS is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
  • KEYS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
87
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $86.88. The Score for KYMR is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

KEYS Stock Price Chart

What is Keysight Technologies, Inc.'s stock price today?

  • The Keysight Technologies, Inc. share price today is $210.46
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KEYS is experiencing slight selling pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $86.88
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

KEYS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.21 Buy
Relative Strength Index (14 RSI): 75.28 Buy
Chaikin Money Flow: -110873 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (175.58 - 201.86) Buy
Bollinger Bands (100): (161.24 - 185.36) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.97 Buy
Relative Strength Index (14 RSI): 72.81 Buy
Chaikin Money Flow: -897315 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.72 - 73.96) Buy
Bollinger Bands (100): (43.27 - 64.19) Buy

KEYS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 205.39 Buy
20-day SMA: 190.18 Buy
50-day SMA: 179.32 Buy
200-day SMA: 163.93 Buy
8-day EMA: 204.59 Buy
20-day EMA: 194.43 Buy
50-day EMA: 183.61 Buy
200-day EMA: 169.07 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.38 Buy
20-day SMA: 67.89 Buy
50-day SMA: 62.54 Buy
200-day SMA: 44.51 Buy
8-day EMA: 75.59 Buy
20-day EMA: 69.41 Buy
50-day EMA: 62.91 Buy
200-day EMA: 49.79 Buy

Keysight Technologies, Inc. Earnings Growth & KEYS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.32 per share, an increase next quarter of $0.30 per share, an increase this year of $0.89 per share, and an increase next year of $1.01 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.36 per share.

Keysight Technologies, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):